Dr. Michael Anthony Berk, MD

Dr. Berk practices at Washington University Clinical Associates in Saint Louis, Missouri.

Dr. Berk's NPI, 1700802014, was assigned on July 14, 2006. Dr. Berk graduated from Indiana University School Of Medicine in 1979. Dr. Berk holds Missouri license R5J82.

Dr. Berk's primary practice is Washington University Clinical Associates, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 333-4100.

Dr. Berk's primary practice is Washington University Clinical Associates in Saint Louis, Missouri. Dr. Berk is also affiliated with Barnes-Jewish Hospital. The medical group on file is Grant Medical & Diabetes Associates. Dmand AI also links Dr. Berk to 5 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berk practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Berk's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Berk is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Berk's licenses on file in 2 states: Missouri and Ohio.

Dmand AI lists chronic diabetes, diabetic emergency, high cholesterol, osteoporosis, overactive thyroid, parathyroid gland disorder, testicular dysfunction and underactive thyroid among the conditions Dr. Berk treats.

CMS data shows 2,989 Medicare services from Dr. Berk across 11 procedure codes in 2024, for 533 Medicare patients. Medicare paid $112,901 for them. Every service was in an office.

CMS counts 533 Medicare patients who saw Dr. Berk in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berk's median patient age at 70, with 50% women.

In 2024, Dr. Berk wrote 16,175 Medicare Part D claims for 1,137 patients. 72% of them were for generic drugs. CMS names the drug for 15,324 of them, across 199 drugs with 11 or more claims each, at $3,266,597 in total drug cost. In 2023, CMS named 14,966 claims across 191 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Berk for performance year 2024, reported as part of a group. Dr. Berk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 614 papers to Dr. Berk, published from 2004 to 2024. 2021 was the busiest year, with 41. The most frequent topics are Bipolar Disorder, Depression and Depressive Disorder, Major. Dr. Berk has published most often in Aust N Z J Psychiatry. Dr. Berk's most frequent co-authors are Flavio Pereira Kapczinski, MD, Andrew Alan Nierenberg, MD and Ajeet Singh, MA, MD, MPH.

CMS Open Payments shows 704 general payments to Dr. Berk from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $120,267.

Dr. Berk graduated from Indiana University School Of Medicine in 1979.

Dr. Berk is in network with 8 carriers, including United Healthcare, Cigna and HCSC. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.